# TNF and IL23 Blocking Agents Gene Expression Ratios in the Psoriatic Arthritis Synovium_(TIGERS) Study

> **NCT04261010** · NA · COMPLETED · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 36 (actual)

## Conditions studied

- Psoriatic Arthritis

## Interventions

- **PROCEDURE:** Global/single cell gene expression profiles obtained from Synovial biopsies

## Key facts

- **NCT ID:** NCT04261010
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-14
- **Primary completion:** 2023-09-12
- **Final completion:** 2023-09-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-09-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04261010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04261010, "TNF and IL23 Blocking Agents Gene Expression Ratios in the Psoriatic Arthritis Synovium_(TIGERS) Study". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT04261010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*